Tempest Therapeutics, Inc.
TPSTBiotechnology
$0.53−1.24%As of Oct 29vs prior close
- Market cap
- $10.7M
- P/E (TTM)
- –
- From 52W high
- −95.07%
- EPS (LTM)
- -$3.97
- Revenue (YE17)
- $295K
Nomior Score
15
Fragile PremiumSpeculativeBottom 4% of the scored universe
Growth—
Quality—
Value22
Momentum6
Resilience24
Growth
−54.82%revenue a year over 1 fiscal year
YE16 $653KYE17 $295K
Connections
Revenue to profitYE17
The gross loss was 168% of revenue, narrower by 559 pts on a year.
Who owns it
1fund